Our finding of impaired AQP4 polarization in affected regions of the tauopathy brain, and the effect of pharmacological AQP4 inhibition, suggest that this water channel may present as a novel target for modulation of this pathway for therapeutic effect in Alzheimer’s disease. The gene discussed is AQP4; the disease is tauopathy.